Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trialJohannes Levin, Johannes Schwarz, Ulrich Mansmann et al.|The Lancet Neurology|2019Cited by 126
A hexanucleotide repeat modifies expressivity of X‐linked dystonia parkinsonismAna Westenberger, Christine Klein, Charles Jourdan Reyes et al.|Annals of Neurology|2019Cited by 96
Therapie und Verlauf neurologischer ErkrankungenBenedikt Schoser, Günther Deuschl, Jörg B. Schulz et al.|Unknown|2023Cited by 68
Bi‐Allelic <scp><i>COQ4</i></scp> Variants Cause Adult‐Onset Ataxia‐Spasticity Spectrum DiseaseIsabell Cordts, Marcus Deschauer, Luisa Semmler et al.|Movement Disorders|2022Cited by 21